Psychiatry & Psychotherapy Podcast Clozapine for Treatment Resistant Schizophrenia
10 snips
Jun 20, 2019 
Michael Cummings, a seasoned psychiatrist with expertise in schizophrenia and psychopharmacology, discusses the unique journey of clozapine, the gold standard for treatment-resistant schizophrenia. He reveals its accidental discovery and how initial concerns about side effects delayed its use in the U.S. The conversation covers clozapine's remarkable efficacy, its complex side effects, and the critical need for careful monitoring. Cummings emphasizes individualized treatment strategies and outlines the importance of addressing lifestyle factors to enhance patient outcomes.
AI Snips
Chapters
Books
Transcript
Episode notes
Manage Clozapine Seizures Safely
- Titrate clozapine slowly starting at 12.5 mg to minimize seizure risk.
- If seizures occur, do not stop clozapine; add antiepileptics like valproic acid or levetiracetam.
Counteract Clozapine Sedation
- Use methylphenidate (Concerta) to counteract clozapine sedation; modafinil is generally ineffective.
- Consolidate clozapine dosing to nighttime to reduce daytime sedation.
Understanding Clozapine Agranulocytosis
- Clozapine-related agranulocytosis is an autoimmune process peaking at one month with a 1% risk.
- Use colony-stimulating factor filgrastim for treatment, improving survival significantly.
